首页 > Ancell > Ancell/anti-CD154/100 g/353-030

提醒：代购产品，无质量问题不接受退换货，下单前请仔细核对信息。下单后请及时联系客服核对商品价格，订单生效后再付款。

Ancell/anti-CD154/100 g/353-030

价格：

登录查看

自营商城

解放采购

正品保障

及时交付

厂家直采

一站服务

货号：

353-030

品牌：

Ancell

会员服务：

尊享会员价

贵宾专线

运费优惠

闪电退款

福利优惠

上门换新

友情提示

以上价格仅为参考，请联系客服询价。

免费咨询热线

4000-520-616

产品说明

Human CD154 (CD40 Ligand) is a member of the tumor necrosis factor (TNF) family and is expressed on the surface of activated T cells. Interaction of CD154 and CD40 is essential for isotype switching in B cells. Known genetic defects that alter this interaction lead to impaired immune system function (1). CD154 has been shown to be hyperexpressed by B and T cells in SLE patients (4). CD154 has been reported to be expressed on vascular endothelial cells, smooth muscle cells and macrophages indicating a possible role for the CD40-CD154 immunoregulatory signaling mechanism during inflammation and immunity in atherogenesis (6). Isotype: Murine IgG1Immunogen: Human sgp39 fusion proteinSpecificity: Antibody 24-31 immunoprecipitates a CD154 (gp39) molecule of about 39 kd. This clone has been reported to cross react with Cynomolgus and Rhesus Monkey CD154.Functional Application: The antibody 24-31 will block MLR, sgp39 induced human B cell proliferation and T cell dependent B cell differentiation (9).References:1. D. Gray, et al, (1994) Seminars in Immunol 6: 303-310.2. F. Pietravalle, et al, (1996) J Biol Chemistry 271: 5965-5967.3. R.J. Noelle, (1996) Immunity 4: 415-419.4. A. Desai-Mehta, et al, (1996) J Clin Invest 97: 2063-2073.5. I.S. Grewal and R.A. Flavell, (1996) Immunol Today 17: 410-414.6. F. Mach, et al, (1997) Proc Natl Acad Sci USA 94:1931-1936.7. F. Pietraville, et al, (1996) Eur J. Immunol 26:725-728.8. U.G. Wagner, C. Weyland, et al, (1998) J Immunol 161: 6390-6397.9. M. Epeldegui, O. Martinez-Maza, et al. (2010) PLOS one 5(7): e11448. PMID: 20625427.10. B Barnhart, L R Covey, et al. (2000) Immunology 99(1): 54-61. PMID: 10651941

Ancell自1992年以来，在Ancell，我们一直在努力生产高质量的免疫学研究工具。我们生活并呼吸着尽可能进行最好的实验室工作以生产出丰富的产品组合的想法。